Found Animals offers Michelson Grants of up to $250,000 USD per year for up to three years of funding for research in pursuit of a single-dose, permanent, nonsurgical sterilization product or technology for use in male and female dogs and cats.
As a mission-driven and product-focused program, the Michelson Prize & Grants funds research based on merit rather than a fixed approval rate. To date, we have approved over 30% of proposals submitted and have committed over $14 million to 30+ approved projects across the globe.
Applicants should also take note of refined Michelson Grant funding criteria, updated in November 2014:
- Approaches targeting cells (such as hypothalamic neurons) inside the blood:brain barrier should not be proposed using rodent species, but instead should involve experiments using dogs and/or cats, since efficiency and safety of constructs crossing that barrier may vary by species.
- Approaches targeting cells (such as hypothalamic neurons) inside the blood:brain barrier must include preliminary data demonstrating that authors’ construct can reach the target and must demonstrate efficacy in inactivating/inhibiting/blocking it.
- Approaches to immunocontraception will not be accepted in proof of concept rodent models; rather, these approaches must be proposed using dogs and/or cats.
- Approaches to immunocontraception in dogs and/or cats must include preliminary data in these species showing an antibody and/or cellular immune response to the target antigen, some preliminary efficacy in suppressing reproduction, and basis for the hypothesis that the treatment will have a long-term effect in both males and females following a single injection.
- Approaches using targeted cytotoxins to destroy discrete populations of cells must demonstrate preliminary data (in vitro or in vivo) demonstrating targeting efficiency, toxin uptake, and effect.
The Michelson Prize & Grants is an international program open to any entity, including academic institutions, biotechnology firms, research institutes, and well-qualified individuals or groups. We encourage applications from scientists from a wide range of disciplines, including, but not limited to, biology, bioengineering, biotechnology, cell biology, endocrinology, gene silencing, immunology, materials science, nanotechnology, neuroscience, pharmacology, reproductive biology, and theriogenology.